When a patient/volunteer being administered a drug under clinical trials or outside trials in the case of a treatment regimen, undergoes an adverse […]
The term biosimilar refers to a pharmaceutical drug that is similar to an originally approved biological product with significant differences in safety and […]
Process Analytical Technology (PAT) is a standard mechanism used by Food and Drug Administration (FDA) to regulate and maintain standards in the process […]